{"schema_version":"1","generated_at":"2026-10-29T02:41:33.387Z","data_as_of":null,"url":"https://www.findmykol.com/kol/joel-trugman","json_url":"https://www.findmykol.com/kol/joel-trugman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"joel-trugman","name":"Joel Trugman","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"AbbVie","institution_url":"https://www.findmykol.com/institution/abbvie","city":"Charlottesville","state":"VA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1114096757","orcid":"0000-0002-2376-8878","openalex":"A5060221986"},"summary":"Joel Trugman is a Neurology physician affiliated with AbbVie. OpenAlex indexes 129 publications with 5,232 citations (h-index 38); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":129,"cited_by_count":5232,"h_index":38,"latest_activity_year":2025,"source":"works"},"trials":{"count":4,"shown":3,"withheld":2,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03939312","title":"Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Allergan","source_url":"https://clinicaltrials.gov/study/NCT03939312","trial_url":"https://www.findmykol.com/trial/NCT03939312"},{"nct":"NCT03777059","title":"12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Allergan","source_url":"https://clinicaltrials.gov/study/NCT03777059","trial_url":"https://www.findmykol.com/trial/NCT03777059"},{"nct":"NCT03700320","title":"Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Allergan","source_url":"https://clinicaltrials.gov/study/NCT03700320","trial_url":"https://www.findmykol.com/trial/NCT03700320"}],"source":"trials"},"funding":{"award_count":3,"fiscal_years":{"first":1987,"last":1999},"rows_total":13,"shown":3,"withheld":10,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"M01RR000847","title":"INTRAVENOUS ABT431 IN PARKINSONS DISEASE","fiscal_year":1999,"organization":"UNIVERSITY OF VIRGINIA CHARLOTTESVILLE","source_url":"https://reporter.nih.gov/quickSearch/M01RR000847"},{"project":"M01RR000847","title":"INTRAVENOUS ABT431 IN PARKINSONS DISEASE","fiscal_year":1998,"organization":"UNIVERSITY OF VIRGINIA CHARLOTTESVILLE","source_url":"https://reporter.nih.gov/quickSearch/M01RR000847"},{"project":"M01RR000847","title":"STUDY OF TOLCAPONE IN PARKINSONIAN PATIENTS WITH END OF DOSE WEARING OFF","fiscal_year":1995,"organization":"UNIVERSITY OF VIRGINIA CHARLOTTESVILLE","source_url":"https://reporter.nih.gov/quickSearch/M01RR000847"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial","year":2025,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-025-03679-7","status":"verified"},{"title":"Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial","year":2024,"journal":"The Lancet Neurology","source_url":"https://doi.org/10.1016/s1474-4422(24)00025-5","status":"verified"},{"title":"Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial","year":2024,"journal":"Neurology","source_url":"https://doi.org/10.1212/wnl.0000000000209584","status":"verified"},{"title":"Atogepant: Mechanism of action, clinical and translational science","year":2024,"journal":"Clinical and Translational Science","source_url":"https://doi.org/10.1111/cts.13707","status":"verified"},{"title":"Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2023,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(23)01049-8","status":"verified"}],"source":"works"},"contact":{"address_1":"LEE ST","city":"Charlottesville","state":"VA","zip":"229080001","phone":"434-924-0000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1114096757","source":"identity"},"similar":[{"name":"Markus P. Kummer","slug":"markus-kummer","institution":"AbbVie","url":"https://www.findmykol.com/kol/markus-kummer","json_url":"https://www.findmykol.com/kol/markus-kummer/profile.json"},{"name":"Knut P. H. Biber","slug":"knut-biber","institution":"AbbVie","url":"https://www.findmykol.com/kol/knut-biber","json_url":"https://www.findmykol.com/kol/knut-biber/profile.json"},{"name":"Helga Lorenz","slug":"helga-lorenz","institution":"AbbVie","url":"https://www.findmykol.com/kol/helga-lorenz","json_url":"https://www.findmykol.com/kol/helga-lorenz/profile.json"},{"name":"H. Küpper","slug":"h-kupper","institution":"AbbVie","url":"https://www.findmykol.com/kol/h-kupper","json_url":"https://www.findmykol.com/kol/h-kupper/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"funding":10,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-07-08","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}